Brandywine Oak Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Brandywine Oak Private Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,545	Closed	-$228K	–	353
2022 Q1	$228K	Buy	+2,545	New	+$235K	0.03%	319
2020 Q1	–	Sell	-2,477	Closed	-$235K	–	264
2019 Q4	$235K	Buy	+2,477	New	+$214K	0.04%	219
2019 Q1	–	Sell	-41,174	Closed	-$2.92M	–	641
2018 Q4	$2.92M	Buy	+41,174	New	+$3.32M	0.66%	30

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Brandywine Oak Private Wealth's XBI Position: Q2 2022 in Review

Brandywine Oak Private Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 2,545 shares — an estimated $228K sold.

Brandywine Oak Private Wealth first reported a position in XBI in Q4 2018 and held it in 3 quarters. The position peaked at $2.92M in Q4 2018. 704 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Brandywine Oak Private Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Brandywine Oak Private Wealth sold 2,545 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $228K.
Brandywine Oak Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 3 quarters.
Brandywine Oak Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $2.92M in Q4 2018.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Brandywine Oak Private Wealth's 13F filing for Q2 2022, filed 22 Jul 2022.